Blood PlateletsPlatelet AggregationPlatelet CountPlatelet AdhesivenessPlatelet Membrane GlycoproteinsPlatelet Factor 4ThrombinAdenosine DiphosphatePlatelet TransfusionSerotoninPlatelet Glycoprotein GPIIb-IIIa ComplexClinical Trials as TopicMegakaryocytesPlatelet Glycoprotein GPIb-IX Complexbeta-ThromboglobulinThrombocytopeniaPlatelet ActivationBlood Platelet DisordersPlatelet Activating FactorPlatelet Function TestsFibrinogenProstanoic AcidsAspirinP-Selectinvon Willebrand FactorAdenine NucleotidesThrombopoiesisBlood Cell CountCollagenBlood CoagulationThromboxane A2HemostasisThrombosisAntigens, Human PlateletThrombopoietinCytoplasmic GranulesRabbitsAlphaprodineErgoloid MesylatesThromboxanesMopidamolTime FactorsBlood PreservationPhotiniaAfibrinogenemiaBleeding TimeCycloheptanesErgotamineIprindoleReceptors, ThromboxaneKineticsCalciumBlood ProteinsEpinephrinePlatelet Membrane Glycoprotein IIbEpoprostenolArachidonic AcidsCell MembraneImipraminePlatelet Aggregation InhibitorsPlatelet Factor 3Microscopy, ElectronOrganoidsBlood Coagulation DisordersDouble-Blind MethodDose-Response Relationship, DrugCytoskeletonAdenosine TriphosphateAntibodies, MonoclonalProstaglandinsCalcimycinClinical Trials, Phase III as TopicArachidonic AcidIsonipecotic AcidsEdetic AcidReceptors, ThrombopoietinMethysergideHeparinImmunochemistryReceptors, Purinergic P2Y12Molecular WeightStilbenesTreatment OutcomeReceptors, ProstaglandinPlatelet Storage Pool DeficiencyResearch DesignRistocetinElectrophoresis, Polyacrylamide GelClinical Trials, Phase II as TopicThrombastheniaOligopeptidesGlycoproteinsPurpura, ThrombocytopenicActininFlow CytometryBinding, CompetitiveClinical Trials, Phase I as TopicActinsPseudopodiaControlled Clinical Trials as Topic